Literature DB >> 12373096

Localization of Triton-insoluble cAMP-dependent kinase type RIbeta in rat and mouse brain.

C Mucignat-Caretta1, A Caretta.   

Abstract

In eukaryotic cells, cAMP regulates many different cellular functions. Its effects are in most cases mediated by cAMP-dependent protein kinases. These consist of two regulatory and two catalytic subunits. In mammals, four different isoforms of cAMP-dependent protein kinases regulatory subunits have been characterized (RIalpha and beta, RIIalpha and beta). These four isoforms show a high level of homology and slightly different biochemical properties. In addition to biochemical properties, a different anatomical distribution of the regulatory isoforms may contribute to determine the specificity of diverse cAMP effects. By immunohistochemistry, the distribution of the detergent-insoluble fraction of RIbeta isoform has been examined in rat and mouse brain. Biochemical fractionation shows that a large fraction of both RIalpha and RIbeta isoforms is bound to the cytoskeleton. RIbeta labelling can be observed only in few locations: Purkinje cells, olfactory mitral cells, lateral thalamic neurons, superior olivary complex neurons. These cell populations are involved in the so called Purkinje cell degeneration. On the other hand, RIalpha aggregates have a more widespread distribution, in brain areas involved in visceroemotional control. At the subcellular level, these two subunits show a different pattern of labelling: in most cells a sharply defined clustered labelling is observed for RIalpha isoforms, while the RIbeta isoform presents a weaker, diffuse intracytoplasmic distribution. Competition experiments point to the presence of, as yet unidentified, different and selective anchoring proteins for the two similar RIalpha and beta isoforms. It is suggested that, as is the case for structural proteins, a different supramolecular organization of similar regulatory proteins may be crucial in order to fulfill different functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12373096     DOI: 10.1023/a:1020613132648

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  8 in total

1.  Differentially expressed three non-coding alternate exons at 5' UTR of regulatory type I beta subunit gene of mouse.

Authors:  Abdul Rouf Banday; Shafquat Azim; Mohammad Tabish
Journal:  Mol Biol Rep       Date:  2011-06-26       Impact factor: 2.316

2.  Protein kinase A regulatory subunit distribution in medulloblastoma.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Marco Redaelli; Domenico D'Avella; Antonio Caretta
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

3.  Selective distribution of protein kinase A regulatory subunit RII{alpha} in rodent gliomas.

Authors:  Carla Mucignat-Caretta; Andrea Cavaggioni; Marco Redaelli; Manuela Malatesta; Carlo Zancanaro; Antonio Caretta
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

4.  Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Domenico D'Avella; Antonio Caretta
Journal:  Cancers (Basel)       Date:  2017-12-21       Impact factor: 6.639

5.  Protein Kinase A Catalytic and Regulatory Subunits Interact Differently in Various Areas of Mouse Brain.

Authors:  Carla Mucignat-Caretta; Antonio Caretta
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

6.  Biochemical characterization and cellular imaging of a novel, membrane permeable fluorescent cAMP analog.

Authors:  Daniela Moll; Anke Prinz; Cornelia M Brendel; Marco Berrera; Katrin Guske; Manuela Zaccolo; Hans-Gottfried Genieser; Friedrich W Herberg
Journal:  BMC Biochem       Date:  2008-06-25       Impact factor: 4.059

7.  Protein kinase a in cancer.

Authors:  Antonio Caretta; Carla Mucignat-Caretta
Journal:  Cancers (Basel)       Date:  2011-02-28       Impact factor: 6.639

8.  Protein Kinase A Distribution in Meningioma.

Authors:  Antonio Caretta; Luca Denaro; Domenico D'Avella; Carla Mucignat-Caretta
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.